FENC - FENNEC PHARMACEUTICALS INC.

QQQ $ 474.51 $ 1.08 (0.23 %)

DIA $ 415.14 $ 2.51 (0.61 %)

SPY $ 561.67 $ 1.40 (0.25 %)

TLT $ 100.29 $ -0.19 (-0.19 %)

GLD $ 238.69 $ 1.10 (0.46 %)

Previous Close

$ 5.39

Open

$ 5.47

Bid

$ 5.42 x 100

Ask

-- x --

Day's Range

$ 5.43 - $ 5.47

52 Week Range

$ 5.00 - $ 11.92

Volume

27,942

Average Volume

Market Cap

147.49M

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

$ 53.93

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-29-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-12-2023	03-31-2023	10-Q
7	03-29-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-12-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K
16	11-16-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	02-14-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-14-2018	03-31-2018	10-Q
27	03-28-2018	12-31-2017	10-K
28	11-13-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-12-2017	03-31-2017	10-Q
31	03-29-2017	12-31-2016	10-K
32	11-14-2016	09-30-2016	10-Q
33	08-12-2016	06-30-2016	10-Q
34	05-12-2016	03-31-2016	10-Q
35	03-28-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-11-2015	06-30-2015	10-Q
38	05-15-2015	03-31-2015	10-Q
39	03-31-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Fenne...
08/22/2024 13:09:13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the ...

Craig-Hallum Maintains Buy on Fennec Pharm...
08/14/2024 12:46:15

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price targ...

Fennec Pharmaceuticals Anticipates That Ca...
08/13/2024 10:08:45

Fennec Pharmaceuticals Q2 2024 GAAP EPS $(...
08/13/2024 10:06:54

Fennec Appoints Jeff Hackman As Its CEO An...
08/05/2024 10:27:56

Fennec Pharma COO Adrian Haigh Departs, Ef...
07/01/2024 10:08:05

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company, today announced that A...

Craig-Hallum Maintains Buy on Fennec Pharm...
05/15/2024 17:53:04

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price targ...

HC Wainwright & Co. Maintains Buy on Fenne...
05/15/2024 11:10:13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the ...

Why Alibaba Shares Are Trading Lower By Ar...
05/14/2024 17:30:43

Fennec Pharmaceuticals Q1 2024 GAAP EPS $0...
05/14/2024 10:27:06

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate o...

HC Wainwright & Co. Maintains Buy on Fenne...
04/04/2024 10:22:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the ...

Earnings Scheduled For March 21, 2024
03/21/2024 10:15:14

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

Fennec Pharmaceuticals Q4 EPS $(0.10) Miss...
03/21/2024 10:02:07

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate...

Fennec Pharmaceuticals's Earnings Outlook
03/20/2024 17:01:46

Craig-Hallum Maintains Buy on Fennec Pharm...
03/18/2024 19:31:35

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

Reported Sunday, Fennec Pharmaceuticals An...
03/18/2024 06:06:21

Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI®, the first and only approve...

Fennec Pharmaceuticals Preliminary Report:...
02/29/2024 12:12:45

Fennec Pharmaceuticals Disclosed That The ...
02/01/2024 11:01:00

Fennec Pharma Announces Incremental $5M In...
12/05/2023 10:58:54

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company focused on improving th...

Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...